This company seems to have been delisted
Reason: Filed for Chapter 11 bankruptcy
Last recorded trade on: March 3, 2023
Source: https://www.sec.gov/Archives/edgar/data/1596946/000095017023003480/qtnt_8k_consens_transact.htm
Reason: Filed for Chapter 11 bankruptcy
Last recorded trade on: March 3, 2023
Source: https://www.sec.gov/Archives/edgar/data/1596946/000095017023003480/qtnt_8k_consens_transact.htm
Quotient
QTNT
₹32.93
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Quotient (QTNT) - Total debt
Total debt on the balance sheet as of December 2022 : ₹23.60 Billion
According to Quotient's latest financial reports the company's total debt is ₹23.60 Billion. A company’s total debt is the sum of all current and non-current debts.
Quotient - Total debt on balance sheet (from 2013 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-03-31 | ₹20.23 B | 47.22% |
| 2021-03-31 | ₹13.74 B | 2.68% |
| 2020-03-31 | ₹13.38 B | 56.48% |
| 2019-03-31 | ₹8.55 B | 51% |
| 2018-03-31 | ₹5.66 B | 6.17% |
| 2017-03-31 | ₹5.33 B | 161.58% |
| 2016-03-31 | ₹2.03 B | 107.39% |
| 2015-03-31 | ₹0.98 B | 6.15% |
| 2014-03-31 | ₹0.92 B | 386.93% |
| 2013-03-31 | ₹0.19 B | 20.81% |
| 2012-03-31 | ₹0.15 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Chembio Diagnostics CEMI | ₹2.17 B | -90.79% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | ₹0.24 B | -98.94% | 🇺🇸 USA |
 Atossa Therapeutics ATOS | N/A | N/A | 🇺🇸 USA |